Abstract 1
Introduction 27
Surgery is widely accepted as a standard therapy for stage I non-small cell lung 28 cancer (NSCLC); however, some patients with stage I NSCLC are not suited for resection 29 mainly because of their poor respiratory function. 30
Stereotactic body radiotherapy (SBRT) has recently been accepted as an 31 alternative therapy for patients with stage I NSCLC who cannot undergo surgery or 32 decline surgery [1] [2] [3] . In a previous study, medically inoperable patients were treated with 33 peripheral T1-T2N0M0 NSCLC using SBRT [4] ; the authors reported 3-year local control 34 rates of 97.6% in a group of 55 patients with a median follow-up of almost 3 years, but 35 distant metastasis was 22.1%. We previously reported a 3-year local control rate of 86.8% 36 and a progression-free rate of 59.2% [5] . 37
Histological findings are important factors for the determination of a treatment 38 strategy and to predict clinical outcomes [6] . In lung SBRT, pathological diagnosis is 39 confirmed in most patients before treatment is administered, however some patients 40 undergo the treatment without histological confirmation due to the risk of adverse events 41 caused by biopsy. Simple and less-invasive alternative methods are needed to stratify 42 patients according to risk of disease progression (DP). 43
Advances in imaging technologies such as diffusion-weighted magnetic resonance 44 imaging (DW-MRI) and In this study, we evaluated whether pre-treatment DW-MRI and PET could be 58 used to predict the clinical outcome of stage I NSCLC outcomes after SBRT and 59 compared their predictive capabilities in the same tumours. 60 61
Materials/Methods 62 Subjects 63
The eligibility criteria for lung SBRT in our hospital were as follows: (1) 64 All MRI examinations were performed using a 1.5T MR unit (Avanto, Siemens, 106
Erlangen, Germany) with a phased-array coil. All patients were imaged in the supine 107 position. Initially, transverse HASTE images were obtained for anatomical identification. 108
Subsequently, both T2-weighted (TR/TE = 2100/85 ms) and DW-MR images with 109 prospective acquisition correlation (PACE) utilising sensitivity encoding (SENSE; with a 110 SENSE factor of 2) and echo planar imaging (EPI; with an EPI factor of 96) were 111 PET/CT was performed, using a combined PET/CT scanner (Discovery ST Elite, GE 135
Healthcare Waukesha, WI, USA). Low-dose CT images were acquired during shallow 136 breathing from the upper thigh to the skull base with a 16-detector row scanner (20-100 137 mA, using the auto-mA setting with a noise index of 30, 120 kV, 0.6 s tube rotation, slice 138 thickness 3.75 mm, matrix 512×512, and a pitch of 1.75). Immediately after CT, a 139 whole-body PET emission scan was performed in 3D-acquisition mode with an 140 acquisition time of 2-3 min per bed position. The PET images were attenuation-corrected 141 using the CT data and were reconstructed with a 3D ordered-subsets expectation 142 maximisation algorithm. The respiratory gating method was not used for the PET scan. 143
The maximum standardised uptake values (SUVmax) were measured at the target lesion by 144 a single observer (YN) with more than 10 years of experience in nuclear medicine. 145 146
Follow-up 147
Follow-up visits were conducted at 1, 2, 3, 6, 9, and 12 months in the first year 148 after SBRT and every 3-6 months thereafter. The plain CT scan was performed every 3 149 months in the first year after treatment and every 3-6 months thereafter. When DP was 150 highly suspected by the CT scan, FDG-PET was also performed. 151
Local progression (LP) was diagnosed based on the recommendations for 152 follow-up imaging established by Huang et al. [17] . Regional lymph node metastases 153
were diagnosed based on CT. FDG-PET results were also considered in diagnosis but 154 histological confirmation was not mandatory. DP was defined as LP, regional lymph node 155 metastases, or distant metastases. 156 157
Statistical analysis 158
The correlation of ADC value and SUVmax with DP after SBRT was evaluated. LP 159 and overall survival (OS) were evaluated in the same manner. To consider the impact that 160 the tumour diameter gives the ADC value and SUVmax, the correlations of ADC value and 161
SUVmax with tumour size were also evaluated. The cumulative incidence of DP and LP 162 was evaluated considering competing risk of non-lung cancer death. The Kaplan-Meier 163 method was used to estimate OS and the Grey-box test and log-rank test were used to 164 detect differences between strata. A p-value < 0.05 was considered statistically significant. The median follow-up period was 28.0 (range, 6.7-37.2) months. DP was 172 observed in nine patients. The first site of progression was local tumour in three patients, 173 regional lymph node in two patients, and distant metastasis in four patients. Seven of the 174 nine DP were diagnosed with CT and FDG-PET. The remaining two patients who 175 developed lung metastases were diagnosed with plain CT. 176
The OS at 24 months was 52% (seven patients died, 95% confidence interval [CI] , 177 26-74%). The cumulative incidence rates of LP and DP were 16% (two patients) and 57%, 178 (nine patients) respectively, at 24 months. 179
ADC value and SUVmax 180
The pre-treatment ADC values ranged from 0.83 to 1.29 × 10 -3 mm 2 /s (median 181
1.04 × 10 -3 mm 2 /s), and SUVmax ranged from 1.5 to 30.0 (median 9.9). There was no 182 statistically significant correlation between ADC value and SUVmax (Fig. 1 ). Fig. 2 /s and SUVmax ≥ 7.9; and 197 low-risk group: all other patients), the numbers of patients were well balanced between 198 the groups (8 and 7 patients for the high-and low-risk groups, respectively). The high-risk 199 group had significantly worse DP (p = 0.036). The cumulative incidence rates of DP were 200 75.0% (six patients) in the high-risk group and 28.6% (two patients) in the low-risk 201 groups, respectively, at 24 months (Fig. 3) . The two groups had a similar number of 202 patients, and similar characteristics (Table 2) . 203
The OS at 24 months was 50% (four patients died) in the high-risk group and 57% 204 (three patients died) in the low-risk group. However, from the viewpoint of cancer specificdeath, the survival rates were 60% (three patients died) in the high-risk group and 83% 206 (one patient died) in the low-risk group. The cumulative incidence rates of LP at 24 207 months were 14% (one patient) in both groups. The tumour diameter, pre-treatment ADC 208 value and SUVmax of the patient in the high-risk group were 28 mm, We found that patients presenting with stage I NSCLC and either a lower ADC 218 value, or with a higher SUVmax tended to have a poor DP after SBRT although the 219 difference was not statistically significant. The use of ADC value and SUVmax in 220 combination was a better predictor for DP than either biological marker alone. between SUVmax and DP, although there was no statistically significant correlation with 231
DP. 232
The conventional PET scan has several problems for evaluation of SUVmax. First, the 233 spatial resolution of the PET scanner is low. Second, the PET image is often blurred due 234 to respiratory motion, especially in the lower lobes of the lung and upper abdominal 235 organs. SUVmax is higher when measured using respiratory gating PET or CT 236 reconstruction than when using conventional techniques in lung tumours [19] . If we had 237 used the respiratory gating method in this study, a significant difference might have been 238
observed. 239
The use of DW-MRI for predicting the therapeutic effect and prognosis is also There was no statistical correlation (p=0.64 and 0.63, respectively). higher SUVmax tended to have worse prognosis, although this result was not significantly significant (p = 0.09 and 0.32, respectively). When applying an optimal cut-off value of the ADC and SUVmax, the lower ADC value and higher SUVmax group had a significantly poorer prognosis (p = 0.036); the combination was a strong predictor for DP. higher SUVmax tended to have worse prognosis, although this result was not significantly significant (p = 0.09 and 0.32, respectively). When applying an optimal cut-off value of the ADC and SUVmax, the lower ADC value and higher SUVmax group had a significantly poorer prognosis (p = 0.036); the combination was a strong predictor for DP.
